173 related articles for article (PubMed ID: 36089070)
1. Trajectories and Prognostic Significance of 6-Minute Walk Test Parameters in Fibrotic Interstitial Lung Disease: A Multicenter Study.
Khor YH; Farooqi M; Hambly N; Johannson KA; Marcoux V; Fisher JH; Assayag D; Manganas H; Khalil N; Kolb M; Ryerson CJ;
Chest; 2023 Feb; 163(2):345-357. PubMed ID: 36089070
[TBL] [Abstract][Full Text] [Related]
2. Incidence and Prognostic Significance of Hypoxemia in Fibrotic Interstitial Lung Disease: An International Cohort Study.
Khor YH; Gutman L; Abu Hussein N; Johannson KA; Glaspole IN; Guler SA; Funke-Chambour M; Geiser T; Goh NSL; Ryerson CJ
Chest; 2021 Sep; 160(3):994-1005. PubMed ID: 33905679
[TBL] [Abstract][Full Text] [Related]
3. Predicting New-onset Exertional and Resting Hypoxemia in Fibrotic Interstitial Lung Disease.
Saleem F; Ryerson CJ; Sarma N; Johannson K; Marcoux V; Fisher J; Assayag D; Manganas H; Khalil N; Morisset J; Glaspole IN; Goh N; Oldham JM; Cox G; Fell C; Gershon AS; Halayko A; Hambly N; Lok SD; Shapera S; To T; Wilcox PG; Wong AW; Kolb M; Khor YH
Ann Am Thorac Soc; 2023 Dec; 20(12):1726-1734. PubMed ID: 37676933
[No Abstract] [Full Text] [Related]
4. Validation of Proposed Criteria for Progressive Pulmonary Fibrosis.
Pugashetti JV; Adegunsoye A; Wu Z; Lee CT; Srikrishnan A; Ghodrati S; Vo V; Renzoni EA; Wells AU; Garcia CK; Chua F; Newton CA; Molyneaux PL; Oldham JM
Am J Respir Crit Care Med; 2023 Jan; 207(1):69-76. PubMed ID: 35943866
[No Abstract] [Full Text] [Related]
5. Exertional hypoxemia is more severe in fibrotic interstitial lung disease than in COPD.
Du Plessis JP; Fernandes S; Jamal R; Camp P; Johannson K; Schaeffer M; Wilcox PG; Guenette JA; Ryerson CJ
Respirology; 2018 Apr; 23(4):392-398. PubMed ID: 29193512
[TBL] [Abstract][Full Text] [Related]
6. Exertional Desaturation Is More Severe in Idiopathic Pulmonary Fibrosis Than in Other Interstitial Lung Diseases.
Otake K; Misu S; Fujikawa T; Sakai H; Tomioka H
Phys Ther Res; 2023; 26(1):32-37. PubMed ID: 37181481
[TBL] [Abstract][Full Text] [Related]
7. Burden of Disease and Productivity Loss in the European Economic Area in Patients Affected by Fibrosing Interstitial Lung Disease.
Løkke A; Castello L; Pinheiro Martins P; Soulard S; Hilberg O
Adv Ther; 2023 Dec; 40(12):5502-5518. PubMed ID: 37837527
[TBL] [Abstract][Full Text] [Related]
8. Clinical Characteristics and Disease Course of Fibrosing Interstitial Lung Disease Patients in a Real-World Setting.
Kilpeläinen M; Hirvonen T; Perkonoja K; Hirsjärvi S
Medicina (Kaunas); 2023 Jan; 59(2):. PubMed ID: 36837481
[No Abstract] [Full Text] [Related]
9. Decreased Survival and Lung Function in Progressive Pulmonary Fibrosis.
Platenburg MGJP; van der Vis JJ; Grutters JC; van Moorsel CHM
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837496
[No Abstract] [Full Text] [Related]
10. Patterns of progression in non-IPF fibrotic interstitial lung disease.
Wells AU
Curr Opin Pulm Med; 2023 Sep; 29(5):459-464. PubMed ID: 37417940
[TBL] [Abstract][Full Text] [Related]
11. Claims-based Prevalence of Disease Progression among Patients with Fibrosing Interstitial Lung Disease Other than Idiopathic Pulmonary Fibrosis in the United States.
Singer D; Bengtson LGS; Conoscenti CS; Laouri M; Shetty SS; Anderson AJ; Brown KK
Ann Am Thorac Soc; 2022 Jul; 19(7):1112-1121. PubMed ID: 35015982
[No Abstract] [Full Text] [Related]
12. Epidemiology and Prognostic Significance of Cough in Fibrotic Interstitial Lung Disease.
Khor YH; Johannson KA; Marcoux V; Fisher JH; Assayag D; Manganas H; Khalil N; Kolb M; Ryerson CJ;
Am J Respir Crit Care Med; 2024 Mar; ():. PubMed ID: 38536110
[No Abstract] [Full Text] [Related]
13. Interstitial Lung Disease: A Review.
Maher TM
JAMA; 2024 May; 331(19):1655-1665. PubMed ID: 38648021
[TBL] [Abstract][Full Text] [Related]
14. Computed Tomography Honeycombing Identifies a Progressive Fibrotic Phenotype with Increased Mortality across Diverse Interstitial Lung Diseases.
Adegunsoye A; Oldham JM; Bellam SK; Montner S; Churpek MM; Noth I; Vij R; Strek ME; Chung JH
Ann Am Thorac Soc; 2019 May; 16(5):580-588. PubMed ID: 30653927
[No Abstract] [Full Text] [Related]
15. Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry.
Hambly N; Farooqi MM; Dvorkin-Gheva A; Donohoe K; Garlick K; Scallan C; Chong SG; MacIsaac S; Assayag D; Johannson KA; Fell CD; Marcoux V; Manganas H; Morisset J; Comes A; Fisher JH; Shapera S; Gershon AS; To T; Wong AW; Sadatsafavi M; Wilcox PG; Halayko AJ; Khalil N; Cox G; Richeldi L; Ryerson CJ; Kolb M
Eur Respir J; 2022 Oct; 60(4):. PubMed ID: 35273032
[TBL] [Abstract][Full Text] [Related]
16. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
Garin MC; Highland KB; Silver RM; Strange C
J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
[TBL] [Abstract][Full Text] [Related]
17. Differences in cerebral oxygenation during exercise in patients with idiopathic pulmonary fibrosis with and without exertional hypoxemia: does exercise intensity matter?
Dipla K; Boutou AK; Markopoulou A; Papadopoulos S; Kritikou S; Pitsiou G; Stanopoulos I; Kioumis I; Zafeiridis A
Pulmonology; 2023; 29(3):221-229. PubMed ID: 34274251
[TBL] [Abstract][Full Text] [Related]
18. Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.
Miyashita K; Kono M; Saito G; Koyanagi Y; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Nakamura Y; Suda T; Nakamura H
Clin Respir J; 2021 Mar; 15(3):336-344. PubMed ID: 33197284
[TBL] [Abstract][Full Text] [Related]
19. Disease Behaviour During the Peri-Diagnostic Period in Patients with Suspected Interstitial Lung Disease: The STARLINER Study.
Wijsenbeek MS; Bendstrup E; Valenzuela C; Henry MT; Moor CC; Jouneau S; Fois AG; Moran-Mendoza O; Anees S; Mirt M; Bengus M; Gilberg F; Kirchgaessler KU; Vancheri C
Adv Ther; 2021 Jul; 38(7):4040-4056. PubMed ID: 34117601
[TBL] [Abstract][Full Text] [Related]
20. Changes in patient-reported outcomes in patients with non-idiopathic pulmonary fibrosis fibrotic interstitial lung disease and progressive pulmonary fibrosis.
Takei R; Matsuda T; Fukihara J; Sasano H; Yamano Y; Yokoyama T; Kataoka K; Kimura T; Suzuki A; Furukawa T; Fukuoka J; Johkoh T; Kondoh Y
Front Med (Lausanne); 2023; 10():1067149. PubMed ID: 37457568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
